1On May 26th, 995, the first leading product, sodium aescinate for injection, went on the market; Set up 12 offices nationwide and start professional promotion.
1996, CIS system is fully imported; Implement "654 1" target management; Established a business strategy with the development of natural drugs as the leading direction.
1997, reforming the company's organizational structure and salary system; Comprehensively promote the construction of corporate culture; June 18, published by Greenleaf Man; On September 2 1 day, the new drug "Keweijia" independently developed was awarded the new drug certificate; 10 June 18, the new international standard factory was fully started; The output value exceeds 100 million yuan.
1998, establishing the international cooperation department to carry out international business and cooperation; The establishment of the Intellectual Property Department began to attach importance to the protection of independent intellectual property rights.
1999 1 month, the research and development center was formally established; In February, the company became a member of APEC China Joint Venture; In June, the relocation of the new factory was successfully completed; In February 65438, the solid preparation workshop passed GMP certification.
In March 2000, the Ministry of Science and Technology recognized it as a national key high-tech enterprise; The Ministry of Personnel of the State has recognized it as a "postdoctoral research center"; Shandong Provincial Science and Technology Commission identified R&D Center as "Shandong Natural Medicine Engineering Technology Research Center"; /kloc-in June of 0/8, the Jin Yezi medal was awarded for the first time in the company's sixth anniversary celebration; On July 18, the freeze-dried powder injection workshop passed GMP certification; The new product Northam is on the market.
200 1, Shandong provincial government awarded the title of "Top Ten High-tech Enterprises in 2000"; Maitongna (sodium aescinate for injection) obtained the domestic invention patent right; Put forward the leading direction of research and development of natural drugs and new preparations; R&D Center officially launched foreign technology transfer and cooperation.
In 2002, the development strategy focusing on orthopedics and neurology was established; Sodium aescinate for injection (metona) was patented in the United States; Ole gel was grandly listed; Keweijia obtained the domestic invention patent right; Innovate and reform the operation mechanism of R&D center, and establish Shandong Luye Natural Medicine R&D Co., Ltd.; International trade has greatly improved. In the same year, the company cooperated with Yantai University to establish the College of Pharmacy.
In 2003, Lutino (glutathione for injection) went on the market.
On June 18, 2004, Luye Company celebrated its 10th anniversary and presented the employees who had worked in the company for 10 with the Gold Leaf Medal. On August 5, the small-volume injection workshop passed the national GMP certification; Sdino(e- calcitonin injection) and Omega (sodium aescinate tablets) are on the market.
In 2005, Green Leaf Research Institute was established; International cooperation between products and R&D is gradually strengthened; The company's two leading products are allowed to register and sell in the Vietnamese market; The new drug independently developed by the company has obtained the new drug certificate and production approval; Freeze-dried powder injection workshop successfully passed GMP review.
In 2006, TGA work was substantially started; Lutino has been successfully registered and sold in Southeast Asian countries; Acquisition of Guangzhou Laitai tumor chemoradiotherapy sensitizer Chemena green leaf training and development center was established; The national science and technology research plan guided the project Ximingting film to pass the acceptance test smoothly; The technical platform for industrial production of small molecular drug microspheres was successfully established.
In 2007, it was identified as the "National Enterprise Intellectual Property Demonstration Creation Unit"; China National Intellectual Property Administration set up an enterprise patent exchange station in the company; New members of the Group: Nanjing Kang Hai Pharmaceutical Co., Ltd., Nanjing Cisco Pharmaceutical Co., Ltd. and Beijing Peking University Weixin Biotechnology Co., Ltd.; Successfully established a national enterprise technology center.
In 2008, 5 12 Wenchuan earthquake, the company responded quickly and actively participated in earthquake relief. Donated medicines worth/kloc-0.03 million yuan, more than 980,000 yuan in cash, and/kloc-0.00 million yuan successively to build two "Green Leaf Anti-seismic Spring Bud Schools". Vice Chairman Chinese People's Political Consultative Conference, Minister of Science and Technology Wan Gang, Vice Minister Liu Yanhua and other leaders inspected the company; Our company became the first batch of "high-tech enterprises" re-recognized. Reg won the Science and Technology Award of China Pharmaceutical Society in 2008; The company's research results of aescin won the "second prize of national scientific and technological progress"
In February 2009, Shandong Luye Pharmaceutical Co., Ltd. passed GLP certification.
On May 13, our company successfully passed the examination of TGA (Therapeutic Goods Administration) in Australia and obtained the GMP certificate of Australian production facilities, covering tablets, capsules, granules, powders and gels.
On September 1 1, Director China National Intellectual Property Administration Tian Lipu came to the company to guide the work.
165438+ 10 In October, Mr. Liu Dianbo, President of Luye Pharmaceutical Group, won the "60 People in 60 Years of China Medicine" award.
20 10 1, the construction of "State Key Laboratory of Long-term Controlled Release and Targeting Technology" was approved.
On June+10, 5438, the Trademark Office of the State Administration for Industry and Commerce strictly examined and determined that the trademark of "Green Leaf" was "China Famous Trademark".